- ►annals.org [PDF] D Menzies, R Long, A Trajman, MJ Dion, J … - Annals of Internal Medicine, 2008 - Am Coll Physicians 418 who started rifampin therapy (risk difference [rifampin minus isoniazid],
2.3% [95% CI, 5% to 0.1%]; P 0.040). Grade 3 or 4 hepatitis occurred in 16 of
422 isoniazid recipients compared with 3 of 418 rifampin recipients (risk ... Cited by 7 - Related articles - All 9 versions
A Tables - Ann Intern Med, 2008 - muhc.ca 418 who started rifampin therapy (risk difference [rifampin minus isoniazid],
2.3% [95% CI, 5% to 0.1%]; P 0.040). Grade 3 or 4 hepatitis occurred in 16 of
422 isoniazid recipients compared with 3 of 418 rifampin recipients (risk ... Related articles - View as HTML - All 7 versions
PP Cook, RA Maldonado, CT Yarnell, D … - Clinical Infectious Diseases, 2006 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 15 - Related articles - BL Direct - All 5 versions
D Menzies, MJ Dion, D Francis, I Parisien, I … - Int J Tuberc Lung Dis - ingentaconnect.com BACKGROUND: Current therapy for latent TB infection (LTBI) is long, and requires
close follow-up. This results in sub-optimal adherence—the major reason for
failure of therapy. METHODS: In an open label randomised trial compar- ing ... Cited by 10 - Related articles - BL Direct - All 4 versions
KR Page, F Sifakis, R Montes de Oca, WA … - Archives of Internal Medicine, 2006 - Am Med Assoc Results A total of 770 patients were prescribed 9 months of isoniazid therapy,
and 1379 patients were prescribed 4 months of rifampin therapy. The percentages
of patients who completed 80% or more of their prescribed treatment were ... Cited by 25 - Related articles - BL Direct - All 4 versions
- ►chestpubs.org A Lardizabal, M Passannante, F Kojakali, C … - Chest, 2006 - chestjournal.chestpubs.org Background: Isoniazid is the standard medication used to treat latent
tuberculosis infection (LTBI). The lengthy treatment with isoniazid, its
perceived hepatotoxicity, and the increasing influx of foreign-born persons ... Cited by 25 - Related articles - BL Direct - All 5 versions
T Maeda, S Banno, S Maeda, T Naniwa, Y … - Modern Rheumatology - Springer Abstract We aimed to determine the sensitivity and specificity of QuantiFERON-TB
Gold (QFT-G) in Japa- nese rheumatoid arthritis (RA) patients with a past
history of tuberculosis (TB). We assessed whether it is possible to ... Related articles - All 2 versions
[CITATION] Treatment of latent tuberculosis infection in HIV-seronegative patients
- ►fetalneonatal.com S Nair, WD Carroll - Archives of Disease in Childhood, 2009 - fetalneonatal.com We report the case of a 13-year-old girl with tuberculosis who developed
persistent symptomatic thrombocytopenia whilst being treated with rifampicin and
isoniazid. There was widespread agreement that rifampicin was the likely ... Related articles - All 4 versions
G Liss, JH Lewis - Expert Opin. Drug Metab. Toxicol., 2009 - informahealthcare.com Background: Given the number of publications appearing annually regarding
drug-induced liver injury (DILI), there remains a need to concisely summarize
each year's new crop of case series and reports as well as the advances in ... Related articles - All 6 versions
